These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 16849581

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
    Matsushita M, Yamazaki R, Ikeda H, Mori T, Sumimoto H, Fujita T, Okamoto S, Ikeda Y, Kawakami Y.
    Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020
    [Abstract] [Full Text] [Related]

  • 3. Tissue-restricted T cell alloresponses across HLA barriers: selection and identification of leukemia-restricted CTL in HLA-mismatched stimulator-responder pairs.
    Fujiwara H, Sconocchia G, Melenhorst J, Eniafe R, Nakamura R, Hensel N, Barrett AJ.
    Bone Marrow Transplant; 2003 Aug; 32(4):371-8. PubMed ID: 12900773
    [Abstract] [Full Text] [Related]

  • 4. Mismatched human leukocyte antigen class II-restricted CD8⁺ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation.
    Hirosawa T, Torikai H, Yanagisawa M, Kamei M, Imahashi N, Demachi-Okamura A, Tanimoto M, Shiraishi K, Ito M, Miyamura K, Shibata K, Kikkawa F, Morishima Y, Takahashi T, Emi N, Kuzushima K, Akatsuka Y.
    Cancer Sci; 2011 Jul; 102(7):1281-6. PubMed ID: 21466613
    [Abstract] [Full Text] [Related]

  • 5. TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells.
    Dolstra H, Fredrix H, van der Meer A, de Witte T, Figdor C, van de Wiel-van Kemenade E.
    Bone Marrow Transplant; 2001 May; 27(10):1087-93. PubMed ID: 11438826
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic T cell activities.
    van Lochem E, de Gast B, Goulmy E.
    Bone Marrow Transplant; 1992 Aug; 10(2):181-3. PubMed ID: 1525608
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
    Xia G, Truitt RL, Johnson BD.
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
    Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A.
    Science; 2002 Mar 15; 295(5562):2097-100. PubMed ID: 11896281
    [Abstract] [Full Text] [Related]

  • 14. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation.
    Wu BY, Guo KY, Song CY, Yang, Li D.
    Bone Marrow Transplant; 2000 Sep 15; 26(6):691-3. PubMed ID: 11035376
    [Abstract] [Full Text] [Related]

  • 15. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
    Liu QF, Li YQ, Yang D, Zhang Y, Yang LJ, Chen SH, Sun J, Liu XL, Zhou SY.
    Chin Med J (Engl); 2004 Mar 15; 117(3):413-8. PubMed ID: 15043783
    [Abstract] [Full Text] [Related]

  • 16. [Graft-versus-leukemia effect by lymphocytes from the first donor after second cord blood transplantation in a patient with T-lymphoblastic lymphoma].
    Nagai K, Hashimoto H, Itoh K, Matsushita A, Shimoji S, Kimura T, Inoue D, Mori M, Nagai Y, Tabata S, Yanagida M, Takahashi T.
    Rinsho Ketsueki; 2010 Jun 15; 51(6):413-21. PubMed ID: 20622488
    [Abstract] [Full Text] [Related]

  • 17. Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity.
    Hartwig UF, Nonn M, Khan S, Link I, Huber C, Herr W.
    Biol Blood Marrow Transplant; 2008 Jan 15; 14(1):99-109. PubMed ID: 18158966
    [Abstract] [Full Text] [Related]

  • 18. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
    Kasai M, Akatsuka Y, Emi N, Taji H, Kohno A, Abe A, Tanimoto M, Kodera Y, Saito H.
    Int J Hematol; 1999 Feb 15; 69(2):112-8. PubMed ID: 10071461
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation.
    Or R, Hadar E, Bitan M, Resnick IB, Aker M, Ackerstein A, Samuel S, Tsirigotis P, Gesundheit B, Slavin S, Shapira MY.
    Biol Blood Marrow Transplant; 2006 Dec 15; 12(12):1295-301. PubMed ID: 17162211
    [Abstract] [Full Text] [Related]

  • 20. Preferential usage of T cell receptor (TCR) V beta by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host disease.
    Jiang YZ, Mavroudis DA, Dermime S, Molldrem J, Hensel NF, Barrett AJ.
    Bone Marrow Transplant; 1997 May 15; 19(9):899-903. PubMed ID: 9156263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.